Nigeria Set To Receive First Shipment of Twice-Yearly HIV Prevention Drug Lenacapavir
Korede Abdullah 
LAGOS, Nigeria – The National Agency for the Control of AIDS (NACA) has announced that Nigeria will receive its first shipment of Lenacapavir (LEN), a twice-yearly HIV prevention drug, by March 2026.
In a statement issued on Monday, the agency said the Federal Government is concluding preparations for the introduction and rollout of the injectable Pre-Exposure Prophylaxis (PrEP) option as part of efforts to strengthen HIV prevention strategies in the country.
According to the agency, “the federal government is finalising preparations for the introduction and rollout of the injectable Pre-Exposure Prophylaxis (PrEP) option as part of its broader commitment to strengthen HIV prevention and accelerate progress toward epidemic control.”
NACA explained that Lenacapavir, which is taken only twice a year, offers a more convenient and effective prevention option for individuals at high risk of HIV infection.
The agency further stated that Nigeria is on course for a phased introduction of the LEN PrEP across priority states, noting that regulatory approvals, health system readiness, trained personnel and community engagement strategies have been put in place.
“The federal government has already completed major rollout requirements, including landscape and readiness assessments across 10 states: Akwa Ibom, Anambra, Benue, Cross River, Ebonyi, the Federal Capital Territory, Gombe, Kano, Kwara and Lagos,” NACA said, adding that Information, Education and Communication materials have also been developed to support public awareness and smooth implementation.
About the Author
Mirian Gom 
Chukwu Obinna 
